Carbinoxamine Maleate is a antihistamine and anticholinergic agent. It was first launched in the United States by the McNeil Corporation under the brand name Clistin. It is now available under the brand name Palgic as 4 mg tablets or 4 mg/5 mL liquid. It is approved by the U.S. Food and Drug Administration (FDA) (specifically at the 4 mg dose/strength) for hay fever (a.k.a. allergic rhinitis, SAR and PAR); vasomotor rhinitis; mild urticaria; angioedema, dermatographism and allergic conjunctivitis. Carbinoxamine is a histamine antagonist, specifically an H1-antagonist. References: Moustafa AA, Hegazy MA, Mohamed D, Ali O. Evaluation of multivariate calibration models with different pre-processing and processing algorithms for a novel resolution and quantitation of spectrally overlapped quaternary mixture in syrup. Spectrochim Acta A Mol Biomol Spectrosc. 2016 Feb 5;154:76-83. doi: 10.1016/j.saa.2015.10.010. Epub 2015 Oct 22. PubMed PMID: 26519913.

纯度：≥98%

CAS：3505-38-2